Bo Yuan Hsiao

Dr. Bo Yuan Hsiao

Institute of biochemistry and molecular Biology, National Yang-Ming University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Cellular Signalling
Verified
Journal Article
Closed access
BHBo Yuan Hsiao
Bo Yuan Hsiao
TCTsun-Kai Chang
Tsun-Kai Chang
IWI-Ting Wu
I-Ting Wu
MCMei-Yu Chen
Mei-Yu Chen

Verified
Journal Article
Open access
PDF file
BHBo Yuan Hsiao
Bo Yuan Hsiao
CCChia-Hsin Chen
Chia-Hsin Chen
HCHo-Yi Chi
Ho-Yi Chi
PYPei-Ru Yen
Pei-Ru Yen
YYYing-Zhen Yu
Ying-Zhen Yu
MCMei-Yu Chen
Mei-Yu Chen
Regulation of cellular actin dynamics is pivotal in driving cell motility. During cancer development, cells migrate to invade and spread; therefore, dysregulation of actin regulators is often associated with cancer progression. Here we report the role of ABRACL, a human homolog of the Dictyostelium actin regulator Costars, in migration and tumorigenic growth of cancer cells. We found a correlation between ABRACL expression and the migratory ability of cancer cells. Cell staining revealed the colocalization of ABRACL and F-actin signals at the leading edge of migrating cells. Analysis of the relative F-/G-actin contents in cells lacking or overexpressing ABRACL suggested that ABRACL promotes cellular actin distribution to the polymerized fraction. Physical interaction between ABRACL and cofilin was supported by immunofluorescence staining and proximity ligation. Additionally, ABRACL hindered cofilin-simulated pyrene F-actin fluorescence decay in vitro, indicating a functional interplay. Lastly, analysis on a colorectal cancer cohort demonstrated that high ABRACL expression was associated with distant metastasis, and further exploration showed that depletion of ABRACL expression in colon cancer cells resulted in reduced cell proliferation and tumorigenic growth. Together, results suggest that ABRACL modulates actin dynamics through its interaction with cofilin and thereby regulates cancer cell migration and participates in cancer pathogenesis.